Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | CPT2 | P23786 | 1/20 | 0.39 |
| ▸ | CPT1A | P50416 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8775496 | 0.74 | KMT2A (0.58) | KMT2ACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL8685481 | 0.73 | KMT2A (0.58) | KMT2ACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL640338 | 0.73 | CYP2C9 (0.59) | CYP2C9CYP2C19 | |
| SCHEMBL5744998 | 0.73 | CHRNA7 (0.56) | — | |
| SCHEMBL4908272 | 0.72 | LMNA (0.59) | KMT2ACYP2C9CYP2C19 | |
| SCHEMBL8622944 | 0.72 | CYP2C19 (0.57) | KMT2ACYP2C9CYP2C19 | |
| SCHEMBL5372083 | 0.71 | CYP2C9 (0.65) | KMT2ACYP2C9CYP2C19 | |
| SCHEMBL640295 | 0.71 | CYP11B1 (0.60) | KMT2ACYP2C9CYP2C19 | |
| SCHEMBL3603338 | 0.70 | SCD (0.51) | CYP2C9CYP2C19CPT2CPT1A | |
| SCHEMBL640459 | 0.70 | CYP2C9 (0.55) | CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0598093-B1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHETASE INHIBITORS | ZENECA LTD (GB) | 1997-11-19 | — | — | EP | claimed |
| EP-0598093-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHETASE INHIBITORS | ZENECA LIMITED (GB) | 1994-05-25 | — | — | EP | claimed |
| WO-1993024486-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHETASE INHIBITORS | ZENECA LIMITED (GB) | 1993-12-09 | — | — | WO | claimed |
| EP-0598093-B1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHETASE INHIBITORS | ZENECA LTD (GB) | 1997-11-19 | — | — | EP | disclosed |
| US-5554613-A | QUINUCLIDINE DERIVATIVES, QUALENE SYNTHASE INHIBITORS, TREATMENT OF HYPERCHOLESTEROLEMIA, ATHEROSCLEROSIS AND FUNGUS INFECTIONS | ZENECA LIMITED (GB) | 1996-09-10 | — | — | US | disclosed |
| EP-0598093-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHETASE INHIBITORS | ZENECA LIMITED (GB) | 1994-05-25 | — | — | EP | disclosed |
| WO-1993024486-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHETASE INHIBITORS | ZENECA LIMITED (GB) | 1993-12-09 | — | — | WO | disclosed |